Group 1 - N必贝特-U (688759) was listed today, opening with a rise of 175.03%, and closing the morning session with a gain of 93.70%, with a trading volume of 26.41 million shares and a turnover of 867 million yuan, resulting in a turnover rate of 56.85% [1][2] - Among the new stocks listed today, N必贝特-U had the smallest increase compared to others, such as N奕材-U which rose by 210.21%, N泰凯英 which increased by 206.13%, and N禾元-U which saw a rise of 202.96% [1][2] - 必贝特 is a biopharmaceutical company focused on innovative drug development, targeting major diseases such as cancer, autoimmune diseases, and metabolic disorders, with a commitment to developing first-in-class drugs and addressing unmet clinical needs [1] Group 2 - The total number of shares issued by the company is 90 million, with an online issuance of 21.6 million shares at a price of 17.78 yuan per share, resulting in a final online subscription rate of 0.04772481% [2] - The total fundraising amount from the initial public offering (IPO) is 1.6 billion yuan, primarily allocated to new drug research and development projects, the establishment of a research and development center in Qingyuan, and the construction of a formulation industrialization base, as well as to supplement working capital [2]
N必贝特-U上午收盘涨93.70% 半日换手率56.85%